Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening

Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening

This study is being done to evaluate the performance of a software that uses artificial intelligence to analyze photographs of the retina to help detect diabetic retinopathy. The study will also assess the safety of the software in combination with a fundus camera already available on the market. This software analyzes retinal photographs to detect more than mild diabetic retinopathy in adults with diabetes. The results will be compared to expert human evaluations.

Inclusion Criteria:

• 22 years old or older
• diabetes or diabetic retinopathy
• understand the study information and able to sign a consent form

Exclusion Criteria:

• cannot tolerate eye imaging tests
• laser treatment or injections
• eye surgery, except for simple cataract surgery
• currently involved in another study
• pregnant
• cannot or do not want to have your eyes dilated
• photodynamic therapy within the last 90 days